Sana Biotechnology, Inc. has an official-source baseline, but the report keeps the decision focused on filings: revenue quality, operating income, cash conversion, balance-sheet risk and the next update.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-28 · Confirms SANA ticker, listed issuer name, exchange and CIK where available.SEC APISEC submissions for Sana Biotechnology, Inc.Retrieved 2026-05-28 · Company identity, filing chronology, fiscal year end, SIC description, addresses and latest filing metadata.SEC XBRL APISEC companyfacts for Sana Biotechnology, Inc.Retrieved 2026-05-28 · XBRL-derived revenue, profit, cash-flow and balance-sheet cross-checks when tagged facts are available.10-KSana Biotechnology, Inc. annual report2026-03-03 · annual report. Used for business description, risk factors, financial statement context, governance chronology or recent event review.10-QSana Biotechnology, Inc. latest quarterly or interim report2026-05-11 · latest quarterly or interim report. Used for business description, risk factors, financial statement context, governance chronology or recent event review.8-KSana Biotechnology, Inc. current report2026-05-15 · current report. Used for business description, risk factors, financial statement context, governance chronology or recent event review.DEFA14ASana Biotechnology, Inc. proxy statement2026-04-24 · proxy statement. Used for business description, risk factors, financial statement context, governance chronology or recent event review.